The winners of the environmental awards,established by the heir to the British throne,each received $1.91 million in prize money after being announced in Singapore.
Muscle-mass preservation is becoming a hot new area in obesity medicine.
From health to fast food,investors are starting to question which companies will be slimmed thanks to weight-loss drugs.
CSL has outlined its growth strategy to investors and played down concerns about weight-loss drugs’ impact on some of its key products.
Shareholders have grilled the biotech giant about its long-term strategy as the stock sits close to 10 per cent lower for the year.
The ASX heavyweight and the nation’s largest healthcare company is looking to make its operations more efficient to counter inflation and currency woes.
Blood plasma giant CSL will set the tone for earnings season this week,having been hit hard after a profit downgrade earlier this year.
The US regulator has again asked for more data on the stem cell treatment maker’s flagship product,which was blocked from approval in 2020 for the same reason.
Whether it’s a medical robot or a high-tech weather station,HSC technology subjects are an opportunity to indulge your passion.
Dragonfly Biosciences wants to bring more of its cannabis-based products to local pharmacies.
The biotechnology giant has downgraded its profit guidance after taking a blow from unfavourable currency movements as it competes for plasma donations.